Screening for Cancers in the Oral CAvity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-75
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media).

The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.

Eligibility criteria

Qualifiers

Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme

lives in somme departement

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Invitation for oral cavity cancer screening

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Picardy - Regional health agency (ARS)

Collaborator

Regional Council Picardie

Collaborator

Regional Observatory of Health and Social Issues in Picardie (OR2S)

Collaborator

Association for the screening of diseases in Somme (Adema 80)

Collaborator

Somme Cancer Registry

Collaborator